Literature DB >> 6641714

Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion.

R Müller, I M Verma, E D Adamson.   

Abstract

The c-onc genes c-fos and c-fms are expressed at high levels specifically in mouse extra-embryonal tissues. Here, we report the results of a detailed analysis of expression of these genes within the developing placenta and extra-embryonal membranes (i.e., yolk sac and amnion). (i) The c-fos gene is expressed at relatively high, but nearly constant levels in the undissected placenta throughout gestation. (ii) The level of c-fos transcripts is greater than or equal to 15-fold higher in the separated outer portion of the midgestation placenta (primarily undifferentiated fetus-derived cytotrophoblast maternal decidua) relative to the inner moiety (predominantly differentiated syncytiotrophoblast). (iii) In the inner placenta and in the extra-embryonal membranes c-fos transcripts accumulate as gestation proceeds. The abundance of c-fos transcripts in the micro-surgically isolated 18th day amnion reaches a level which is two orders of magnitude greater than that in midgestation fetuses, and is thus close to the level of v-fos transcripts in virus-transformed cells. (iv) The distribution of c-fos transcripts within the developing extra-embryonal tissues is markedly different from that of the c-fms gene. It is suggested that the c-fos and c-fms proteins may participate in differentiation, growth or transport processes occurring in mouse extra-embryonal tissues.

Entities:  

Mesh:

Year:  1983        PMID: 6641714      PMCID: PMC555169          DOI: 10.1002/j.1460-2075.1983.tb01484.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Histochemical comparison of naphthol AS-phosphates for the demonstration of phosphatases.

Authors:  M S BURSTONE
Journal:  J Natl Cancer Inst       Date:  1958-03       Impact factor: 13.506

2.  Lectin-agarose immobilization, a new method for detecting soluble membrane receptors. Application to studies with epidermal growth factor-urogastrone and transcobalamin-II.

Authors:  E Nexł; R A Hock; M D Hollenberg
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

3.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.

Authors:  R Müller; D J Slamon; J M Tremblay; M J Cline; I M Verma
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

4.  Characterization of a rat yolk sac carcinoma cell line.

Authors:  U Wewer
Journal:  Dev Biol       Date:  1982-10       Impact factor: 3.582

5.  Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences.

Authors:  M M Harpold; R M Evans; M Salditt-Georgieff; J E Darnell
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

6.  Differential expression of the amv gene in human hematopoietic cells.

Authors:  E H Westin; R C Gallo; S K Arya; A Eva; L M Souza; M A Baluda; S A Aaronson; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.

Authors:  T Curran; G Peters; C Van Beveren; N M Teich; I M Verma
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

8.  Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus.

Authors:  R W Ellis; D DeFeo; J M Maryak; H A Young; T Y Shih; E H Chang; D R Lowy; E M Scolnick
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.

Authors:  E H Westin; F Wong-Staal; E P Gelmann; R Dalla-Favera; T S Papas; J A Lautenberger; A Eva; E P Reddy; S R Tronick; S A Aaronson; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

10.  Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.

Authors:  C Van Beveren; F van Straaten; T Curran; R Müller; I M Verma
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

View more
  37 in total

1.  Chromatin association and DNA binding properties of the c-fos proto-oncogene product.

Authors:  M Renz; B Verrier; C Kurz; R Müller
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

2.  Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development.

Authors:  A Jakobovits; G M Shackleford; H E Varmus; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Localization of molecules with restricted patterns of expression in morphogenesis: an immunohistochemical approach.

Authors:  A Thibodeau; J Duchaine; J L Simard; M Vincent
Journal:  Histochem J       Date:  1989-06

4.  Retinol-binding protein and transthyretin mRNA levels in visceral yolk sac and liver during fetal development in the rat.

Authors:  D R Soprano; K J Soprano; D S Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development.

Authors:  R J Arceci; F Shanahan; E R Stanley; J W Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 6.  Human oncogenes.

Authors:  K Willecke; R Schäfer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Human c-fms proto-oncogene: comparative analysis with an abnormal allele.

Authors:  J S Verbeek; A J Roebroek; A M van den Ouweland; H P Bloemers; W J Van de Ven
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

8.  Detection of fetomaternal genotype associations in early-onset disorders: evaluation of different methods and their application to childhood leukemia.

Authors:  Jasmine Healy; Mathieu Bourgey; Chantal Richer; Daniel Sinnett; Marie-Helene Roy-Gagnon
Journal:  J Biomed Biotechnol       Date:  2010-06-09

9.  Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells.

Authors:  G L Mutter; D J Wolgemuth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Suppression of c-fos precursor RNA splicing by the protein kinase C inhibitor H7 [1-(5-isoquinolinesulphonyl)-2-methylpiperazine].

Authors:  M Harbers; H Hilz
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.